NCT03248401View on ClinicalTrials.gov

Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 26, 2016

Primary Completion Date

October 21, 2018

Study Completion Date

December 31, 2019

Conditions
Type 2 Diabetes MellitusCarotid Atherosclerosis
Interventions
DRUG

Cilostazol

Cilostazol 200 mg/day

DRUG

Aspirin

Aspirin 100 mg/day

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT03248401 - Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter